Background and objective The clinical relevance of pleural effusions in lung cancer has
seldom been approached systematically. The aim of this study was to determine the …

Malignant pleural effusion (MPE) is common and difficult to treat. In the vast majority of
patients the presence of MPE heralds incurable disease, associated with poor quality of life …

Although cytology and pleural biopsy of pleural effusion (PE) are the gold standards for
diagnosing malignant pleural effusion (MPE), these tools' diagnostic accuracy is plagued by …

Lung cancer is the leading cause of cancer-related death in both men and women, and non-
small cell histology accounts for 80 to 85% of cases. 1 The staging of non-small cell lung …

Abstract Background and Aims Lung cancer is the most common cause of malignant pleural
effusions (MPE s). For patients with lung cancer and MPE, median survival is only 3–4 …

Malignant pleural effusion (MPE) affects more than 1 million people globally. There is a
dearth of evidence on the therapeutic approach to MPE, and not surprisingly a high degree …

Malignant pleural effusions (MPEs) are an important cause of cancer-related mortality and
morbidity. It is a heterogeneous group of conditions, which leads to debilitating symptoms …

Background The main goal of management in patients with non-small cell lung cancer
(NSCLC) and malignant pleural effusion (MPE) is palliation. Patients with MPE and …

Malignant pleural effusion (MPE) accompanying lung adenocarcinoma indicates poor
prognosis and early metastasis. This study aimed to identify genes related to MPE formation …

Malignant pleural effusion (MPE) is a severe medical condition, which can result in
breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types …